News & Events

We are proud to announce the first-ever launch of Semaglutide injections in Myanmar under the brand name ORSEMA – a breakthrough therapy for diabetes and weight management that is transforming global healthcare standards.

This milestone reflects Incepta’s commitment to innovation and patient care, ensuring that advanced treatment options reach those who need them most. Bringing ORSEMA to Myanmar ahead of time was possible thanks to dedication, collaboration, and strategic partnerships.

A special note of appreciation to ABC International ,Myanmar and all stakeholders who contributed to making this vision a reality. Your support and hard work have set a new benchmark for excellence.